C07K 16/2869
Against hormone receptors
Official title: {against hormone receptors (for antibodies against neuromediator receptors C07K16/286)}
C07K16/2869 (Against hormone receptors) appears on 536 US grants and 835 published applications in this corpus.
Search patents in C07K- Granted patents
- 536
- Published applications
- 835
- Assignees
- 334
- Inventors
- 1,310
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 5 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 3 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 8 | 1 |
| 2002 | 6 | 8 |
| 2003 | 4 | 19 |
| 2004 | 6 | 15 |
| 2005 | 3 | 13 |
| 2006 | 10 | 9 |
| 2007 | 6 | 17 |
| 2008 | 3 | 14 |
| 2009 | 6 | 20 |
| 2010 | 10 | 22 |
| 2011 | 11 | 28 |
| 2012 | 18 | 22 |
| 2013 | 21 | 40 |
| 2014 | 27 | 39 |
| 2015 | 23 | 36 |
| 2016 | 29 | 49 |
| 2017 | 29 | 51 |
| 2018 | 36 | 49 |
| 2019 | 40 | 58 |
| 2020 | 29 | 47 |
| 2021 | 36 | 58 |
| 2022 | 36 | 71 |
| 2023 | 22 | 38 |
| 2024 | 26 | 36 |
| 2025 | 35 | 44 |
| 2026 | 19 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Targeting of human interferon antagonists22 Sep 2026US 12,741,998 B2Centre Hospitalier Regional Universitaire De Montpellier
- Monospecific antibodies that antagonize leptin receptor25 Aug 2026US 12,715,927 B2Regeneron Pharmaceuticals, Inc.
- Parathyroid hormone receptor 1(PTH1R) antibodies and uses thereof4 Aug 2026US 12,698,346 B2Xoma (US) LLC
- Bifunctional degraders for the treatment of Graves' disease21 Jul 2026US 12,685,782 B2Biohaven Therapeutics Ltd.
- Methods for making stable protein compositions14 Jul 2026US 12,679,865 B2Amgen Inc.
- Growth hormone targeting polypeptides1 Oct 2026US 2026/0297205 A1The University of Chicago
- Antibody binding to thyroid-stimulating hormone receptor and use thereof24 Sep 2026US 2026/0285991 A1Shanghai Scizeng Medical Technology Co., Ltd.
- Gip activity modulators and orthostatic intolerance24 Sep 2026US 2026/0285992 A1Antag Therapeutics ApS
- Prolactin Receptor Antibody and Use Thereof24 Sep 2026US 2026/0285993 A1
- Anti-mullerian hormone receptor binding peptides17 Sep 2026US 2026/0274975 A1Ovares D LLC
Most cited
By later US patents
- Method for making multispecific antibodies having heteromultimeric and common components266US 7,183,076 B2Genentech, Inc. · 2007
- Polynucleotides encoding insect steroid hormone receptor polypeptides and cells transformed with same93US 5,514,578 AThe Board of Trustees of the Leland Stanford University · 1996
- Fed-batch cell culture methods using non-animal-based hydrolysates79US 8,093,045 B2Abbott Laboratories · 2012
- Selecting ligand agonists and antagonists77US 5,506,107 AGenentech, Inc. · 1996
- Polynucleotide encoding insect ecdysone receptor72US 6,245,531 B1The Board of Trustees of the Leland Stanford University · 2001